US FDA approves Imfinzi for unresectable Stage III non-small cell lung cancer
AstraZeneca and MedImmune, its global biologics research and development arm, got clearance from the FDA to have Imfinzi for the…
Pharmaceuticals, Biotechnology and Life Sciences
AstraZeneca and MedImmune, its global biologics research and development arm, got clearance from the FDA to have Imfinzi for the…
Creso Pharma Limited has completed the acquisition of emerging Nova Scotia-based medicinal cannabis producer, Mernova Medicinal Inc (Mernova).
Celgene Corporation said Monday that data from the phase III Relief clinical trial of Otezla in patients with active Behçet’s…
Apricus Biosciences, a biopharmaceutical company urology and rheumatology focused drug-maker, will have to fire another shot at getting its topical cream…
Premaitha Health has signed an agreement to offer the IONA test across Egypt. As a result of, Premaitha has secured…
Johnson & Johnson’s Janssen has welcomed the news from Health Canada as it got approval to use Zytiga combined with prednisone…
Accelerate Diagnostics has doubled its revenues in the last quarter of 2017 compared to the last year’s same period. The…
Akcea Therapeutics will be waiting August 2018, and expecting affirmation from FDA’s Metabolism and Endocrinology division for its treatment against…
The U.S. Food and Drug Administration has allowed of the first blood test to evaluate mild traumatic brain injury (mTBI),…
AstraZeneca and Merck will have a new Orphan Drug Designation in selumetinib, a MEK 1/2 inhibitor, as the US Food and…